Interestingly, Cyst(e)inase synergized with radiotherapy to inhibit tumor growth in the B16 melanoma model (113) and also synergized with immune checkpoint therapy (i.e., anti-PDL1) to promote cytotoxic CD8 T cell antitumor immune response in ovarian-tumor-bearing mice (86). The gene discussed is CD8A; the disease is melanoma.